Chou-Pin Chen
Overview
Explore the profile of Chou-Pin Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu C, Mong M, Tzeng H, Yang M, Chen J, Hsia T, et al.
In Vivo
. 2023 Dec;
38(1):90-97.
PMID: 38148080
Background/aim: Elevated serum interleukin-16 (IL-16) levels have been reported in gastric cancer (GC) tissues; however, the role of IL-16 genotypes in GC susceptibility remains largely unexplored. This study aimed to...
2.
Huang C, Hu H, Hsu W, Chen C, Huang M, Chen C, et al.
Nanomedicine (Lond)
. 2023 May;
18(6):511-524.
PMID: 37166053
To investigate the safety profile, dose-limiting toxicity and antitumor activity of PEP503 (NBTXR3) nanoparticles with radiotherapy and concurrent chemotherapy in patients with locally advanced or unresectable rectal cancer. Patients will...
3.
Yueh T, Tsao H, Chien W, Tsai C, Pei J, Wu M, et al.
Anticancer Res
. 2022 Oct;
42(11):5275-5282.
PMID: 36288882
Background/aim: Metalloproteinase-7 (MMP-7) has been previously found to be up-regulated in hepatocellular carcinoma (HCC) specimens and cells, favoring epithelial-mesenchymal transition. However, the contribution of MMP-7 genotypes to HCC has not...
4.
Wu M, Chen C, Chen C, Huang T, Yueh T, Wang Z, et al.
Anticancer Res
. 2022 Apr;
42(5):2375-2382.
PMID: 35489763
Background/aim: 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) is responsible for folate metabolism, and we aimed to investigate its genetic role in colorectal cancer (CRC) among Taiwanese. Materials And Methods: A total of...
5.
Chen C, Ke T, Cheng R, Wang J
Transl Cancer Res
. 2022 Feb;
9(9):5645-5654.
PMID: 35117928
The development of new anti-angiogenic agents targeting the vascular endothelial growth factor (VEGF) and epidermal growth factor receptor pathways has greatly expanded the therapeutic options for patients with metastatic colorectal...
6.
Lin C, Chen C, Chiang F, Chen C, Chen M, Chen C, et al.
Surg Laparosc Endosc Percutan Tech
. 2021 Oct;
32(1):101-106.
PMID: 34653111
Background: For minimally invasive colorectal surgery, preoperative localization is a typical procedure. We here aimed to analyze compared 2 different localization methods in terms of short-term outcomes, like the operative...
7.
Chen C, Chen C, Yao P
Asian J Surg
. 2021 Jul;
44(10):1310-1311.
PMID: 34330592
No abstract available.
8.
Lin C, Chen T, Wu Y, Fang C, Wang J, Chen C, et al.
Ann Surg Oncol
. 2020 Sep;
28(3):1762-1776.
PMID: 32875464
Background: Taiwan has witnessed a surge in the incidence of colorectal cancer (CRC), of which 40-60% metastasize. Continuous updating of cytoreductive strategies in metastatic CRC (mCRC) has contributed to median...
9.
Hung Y, Chang W, Chou A, Pei J, Yang M, Yang H, et al.
Anticancer Res
. 2020 Mar;
40(3):1297-1306.
PMID: 32132026
Aim: To investigate the association between adiponectin (ADIPOQ) genotypes and colorectal cancer (CRC) risk among Taiwanese. Materials And Methods: Polymerase chain reaction-restriction fragment length polymorphism was adopted to identify ADIPOQ...
10.
Lin C, Lin T, Chen C, Chen M, Chen C
PLoS One
. 2018 Jan;
13(1):e0190497.
PMID: 29304109
Background: Regorafenib has been demonstrated as effective in refractory metastatic colorectal cancer. Combination use with chemotherapy has not been reported. We examined the efficacy and safety of adding chemotherapy to...